In a significant move aimed at strengthening patient safety and ensuring the rational use of medicines, the Central Government has banned the manufacture, sale, distribution, and supply of 16 Fixed-Dose Combination (FDC) drugs across India with immediate effect. According to the Union Health Ministry, these medicines were found to lack adequate therapeutic justification, and their potential risks were considered greater than their expected benefits. The decision has been take